To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
11 Current news of Novaseprss
New plant on its Mourenx, France site to produce a large volume commercial API
Novasep announced an investment of EUR 30 million to build in Europe what will be the world's largest chromatography plant used for the production of a large volume commercial API (active pharmaceutical ingredient).The plant will be built on Novasep's existing Mourenx site in France and will ...
Novasep announces a EUR three million investment to expand its Highly Potent API (HPAPI) manufacturing capabilities at its facility in Le Mans, France. The expansion has been designed to allow Novasep to serve the increased demand for manufacturing of novel anti-cancer therapies. Demand in ...
Appointment of Jean-Claude Romain as corporate quality director and Alain Lamproye as director of Novasep Bioproduction sites in Belgium
Novasep announced two new managerial appointments. Jean-Claude Romain becomes the group's corporate quality director and a member of Novasep's executive committee, while Alain Lamproye joins Novasep Process, the company's biomolecules division, as director of Novasep Belgium and becomes a ...
New site increases Novasep’s process development and engineering capabilities to supply turnkey purification processes in East Asia
Novasep announced the opening of a new 2,000 m2 facility in Shanghai Pudong district, China. The site will boost Novasep's process development and engineering capabilities to cater for ever-increasing Chinese and East Asian demand. These facilities will also add to Novasep’s existing 12 ...
Novasep’s pharmaceutical production excellence in Europe and the Bahamas recognized by two successful FDA inspections in 2011
Novasep announced today that it has completed two successful US Food and Drug Administration (FDA) inspections for Novasep Synthesis in 2011. All five Novasep Synthesis sites passed FDA inspections in the last three years, the most recent ones at its Freeport (the Bahamas) facility in March ...
Companies will develop solutions to change manufacturing paradigm for new and generic anti-cancer compounds
Novasep, a leading supplier of manufacturing solutions to the life science industries, and instrAction, a manufacturer of innovative chromatographic stationary phases for API purification processes, announced they have expanded their worldwide strategic alliance to include the purification of ...
Nutritis and Novasep Process, a division of Novasep, announced that, thanks to Novasep Process, Nutritis will scale up its production process for fructose from apple juice. Nutritis brought in Novasep to use the latter’s purification expertise to scale up its innovative process. Nutritis and ...
Bernard Dubois, Former Aventis Senior VP of Global Industrial Operations Brings a Wealth of Experience to Novasep's Top Management Team
Novasep announced the appointment of Bernard Dubois as Chairman of its supervisory board. Bernard Dubois replaces Pietro Stefanutti, who decided to allocate most of his time to personal activities. As a graduate of the renowned Ecole Polytechnique (France) with an MBA from Cornell University ...
Cerenis Therapeutics SA and Groupe Novasep announced that they have received French Government funding through OSEO to finance the development of CER-001, a Cerenis HDL mimetic. CER-001 represents a promising new approach in the fight against atherosclerotic cardiovascular disease and has ...
Novasep and instrAction announced that they have entered a strategic alliance. The alliance will offer customers in the life science industry a combination of instrAction’s proprietary API-selective stationary phases (Instruction® Receptor Phase) and Novasep purification capabilities and high ...